13th GCC Closed Forum for Bioanalysis

New Orleans, LA, USA (Hyatt Regency New Orleans)

11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validation - This Conference Report has just been published on Bioanalysis Journal

Based on Sankeetha Nadarajah and Hannah Makin, Commissioning Editors of Future Sciences, 10th GCC Closed Forum Conference Report is ranked as the Number One Most Read article published by Bioanalysis Journal in year 2017!
Read Sankeetha and Hannah's article at https://www.future-science.com/doi/pdf/10.4155/bio-2017-4972

10th GCC Closed Forum: rejected data, GCP in bioanalysis, extract stability, BAV, processed batch acceptance, matrix stability, critical reagents, ELN and data integrity and counteracting fraud - This Conference Report was published on Bioanalysis Journal

9th GCC: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooks - This Conference Report was published on Bioanalysis Journal

8th GCC: Consolidated feedback to US FDA on the 2013 Draft FDA Guidance on Bioanalytical Method Validation - This Conference Report was published on Bioanalysis Journal

WHITE PAPER - Recommendations on Incurred Sample Stability (ISS) by GCC - This White Paper was published on Bioanalysis Journal

WHITE PAPER - Recommendations on Biomarker Bioanalytical Validation by GCC - This White Paper was published on Bioanalysis Journal

View More...